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ABSTRACT
The serological diagnosis of blood culture-negative endocarditis due to Coxiella burnetii, Bartonella spp.,
Brucella melitensis and Legionella pneumophila is based on a manual immunoﬂuorescence assay (IFA),
which is taken to be the reference method. The automated IFA InoDiag multiplexed antigenic
microarray, which includes a slide with all the above bacteria and four internal controls, an incubator, a
ﬂuorescent reader and software with an algorithm of interpretation for infectious endocarditis (IE) was
evaluated. A single serum dilution at 1 ⁄ 128 was used. Eleven patients with Bartonella spp. IE and ten
with C. burnetii IE, diagnosed using the modiﬁed Duke criteria, as well as one patient with B. melitensis
infection and three patients with L. pneumophila IE were tested. In total, 236 sera were used as negative
controls, with the reference method. The results of IgG detection were: C. burnetii phase I, ‘sensitivity
(Se) = 88% and speciﬁcity (Sp) = 99%’, and C. burnetii phase II, Se = 88% and Sp = 99%; for Bartonella
henselae, Se = 100% and Sp = 100%; for Bartonella quintana, Se = 78% and Sp = 96%; for B. melitensis,
Se = 100% and Sp = 99%; and for L. pneumophila, Se = 100% and Sp = 99%. With the algorithm
interpretation, the negative and positive predictive values of the test ‘were 100% for the diagnosis of IE
caused by the four bacteria tested. These results were conﬁrmed by two other assays, one using triplicate
testing and one blind testing performed by another centre. This multiplexed test is therefore a valuable
tool for the rapid diagnosis of blood-culture negative IE.
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INTRODUCTION
The diagnosis of infectious diseases due to fastid-
ious bacteria is usually based on serology. Bacterial
culture cannot be achieved in most routine labora-
tories because of the fastidious and hazardous
conditions of growth of bacteria such as Coxiella
burnetii, Bartonella sp., Brucella melitensis and
Legionella pneumophila. These pathogens are
‘aetiological agents’ of blood culture-negative
infectious endocarditis [1] (IE). The most common
serological method is indirect immunoﬂuores-
cence assay (IFA). IFA is technically demanding
and requires a technician and long-standing labo-
ratory experience. The use of ﬂuorescence micro-
scopy is known to lack reproducibility, e.g. in the
case of Lyme disease [2–4]. Most of the serological
assays include only one pathogen per test, and
serial dilutions are needed for the positive sera,
thus delaying diagnosis. Rolain et al. introduced
the concept of unique dilution for the diagnosis of
Bartonella sp. and C. burnetii endocarditis [5], and
signiﬁcant results were reported (sensitivity 100%,
positive predictive value).
Slides are available for multiplex serodiagno-
sis of infectious diseases (Euroimmun, Lubeck,
Germany; PNEUMOBACT, Vircell, Spain) with
IFA or ELISA tests. But these multiplex serological
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assays are not fully automated for ELISA and are
manual for IFA. In the case of IE, thismultiplex test,
used’ at a single dilution, would be helpful for a
rapid diagnosis. All the bacteria known to cause a
deﬁned clinical syndrome, e.g. IE, would be tested
simultaneously, greatly improving efﬁciency in
serological testing. Multiplexed detection trials
have previously been undertaken. For example,
Biagini et al. detected antibodies against ﬁve bio-
terrorism agents using, simultaneously, immuno-
reactive, ﬂuorescent beads [6].
Others have developed a microarray format
incorporating puriﬁed, immunodominant anti-
gens of agents involved in threats to pregnancy,
e.g. Toxoplasma gondii, cytomegalovirus, herpes
simplex virus and rubella virus [7].
The objective of this study was to compare the
multiplexed automated corpuscular antigenic
microarray (MACAM) with the reference method.
The MACAM incorporated nanospots of whole
puriﬁed bacteria without cells, similar to those
used for manual IFA, and four systematically
incorporated controls. A fully automated incuba-
tor and ﬂuorescence reader were used to establish
the ﬁrst MACAM ﬂuorescent system for serology.
Tests were performed for the serological diagno-
sis of blood culture-negative endocarditis using a
single dilution of serum.
MATERIALS AND METHODS
Patients and controls
Patients were all those admitted to la Timone Hospital’,
University of Marseilles, France, between April 2000 and
December 2005 with clinical suspicion of IE. IE was diag-
nosed using the modiﬁed Duke criteria [8,9]. In total, 25
serum samples of patients with blood culture-negative
endocarditis and 236 control sera tested negative with the
reference technique. These samples were previously tested
for the presence of L. pneumophila, Bartonella henselae, Barto-
nella quintana, C. burnetii [10] and B. melitensis antibodies. The
serological tests were performed using IFA commercial slides
for L. pneumophila (Virotech) [11], with an agglutination kit
(Biorad, Marnes-la coquette, France) for ‘B. melitensis and
using IFA in-house slides for Bartonella henselae [12], Bartonella
quintana [12] and C. burnetii. Bartonella quintana (Oklahoma
strain, ATCC 51694) and Bartonella henselae (Marseille strain,
ATCC 49882) were prepared as previously described [13–15].
C. burnetii phase I and phase II (Nine Mile strain, ATCC
VR-616) were prepared as previously described [10]. All
‘manipulations were conducted at biohazard safety level 3’.
As previously demonstrated [16,17], a cut-off titre for Bartonella
spp. of ‡1 ⁄ 400 was used to diagnose endocarditis. Similarly,
C. burnetii anti-phase I IgG titres of ‡1 ⁄ 800 were considered to
represent a major criterion for the diagnosis of IE [18].
The 25 sera were collected from patients during a period
between 10 days and 1 month before the onset of the disease
and prior to the treatment. Patients included ten with Barto-
nella sp. IE, ﬁve with Bartonella quintana IE, with IgG titre
‡1 ⁄ 800, ﬁve with Bartonella henselae IE, with IgG titre ‡1 ⁄ 800
(diagnosed using western blot because of cross-reaction), and
one with Bartonella henselae endocarditis that was negative
according to IFA, but positive according to western blot.
Ten patients with C. burnetii IE with IgG phase I titre
‡1 ⁄ 1600, one patient with B. melitensis infection with Ig(G+M)
‡1 ⁄ 1280, and three patients with L. pneumophila serotype I
infection (two with anti-L. pneumophila IgT ‡1 ⁄ 512, and one
with IgT ‡1 ⁄ 1024) were included. Three groups of negative
control sera (n = 236) were tested. The ﬁrst group comprised
22 sera collected from blood donors and veriﬁed as negative
for the speciﬁc antigens. The second group comprised sera
from 187 patients suspected of having endocarditis but
‘classiﬁed as rejected cases of IE according to the modiﬁed
Duke criteria’ and veriﬁed as negative for each speciﬁc
antigen. The third group comprised 27 sera potentially leading
to false-positive reactivity because of antinuclear antibodies
(n = 5), myeloma (n = 5), malaria (n = 5), Epstein–Barr virus
acute infection (n = 2), cytomegalovirus acute infection (n = 5)
and rheumatoid factors (n = 5). Sera were blindly controlled in
parallel using the reference method for each one of the six
speciﬁc antigens.
InoDiag slide
‘InoDiag developed multiplexed glass slides that were spotted
with ‘one nanolitre ‘of antigens deposited by a ‘Affymetrix
Arrayer 417 ‘spotter. ‘These slides were ‘used to analyse
simultaneously the immunological response (IgG and IgM)
against various antigens with a ﬂuorescent camera analyser.’
The multiplexed slide tests have 15 spots: four controls and
11 antigens. The four controls used were: a Staphylococcus
aureus (ATCC 29213) spot to verify serum deposition [5], a
human IgG (Serotec, Oxford, UK) spot to verify the secondary
antibody distribution and to detect the presence of rheumatoid
factor, a human IgM (Sigma St. Quentin, Fallavier, France)
spot’ to verify the secondary antibody distribution, and
‘dsDNA (Diarect, Freiburg, Germany) to detect the presence
of antinuclear antibodies. ‘The nanospots included each of the
following antigens’: Bartonella quintana (Oklahoma strain,
ATCC 51694), Bartonella henselae (Marseille strain, ATCC
49882), C. burnetii phase I and phase II (Nine Mile strain,
ATCC VR-616), L. pneumophila serogroup 1 (ATCC 33152),
and B. melitensis (ATCC 23456).
Automated IFA
Four InoDiag slides were incubated simultaneously, at room
temperature, on the automated incubator (InoDiag, La Ciotat,
France) within 1 h. Sera were diluted at 1 ⁄ 128 in phosphate-
buffered saline (PBS) (5 lL of serum were diluted in 635 lL of
PBS). Fifty lL of this dilution were used for the test. ‘The
serum was’ distributed in circular steel chambers. One spotted
slide was clamped over each of four chambers, allowing
sealing and contact between the sample and the deposit. ‘Next,
the entire IFA reaction step was automated, including the
serum and the secondary antibody incubation, and the
washing and drying steps. Brieﬂy, the assay involves 20 min
of incubation of the diluted sample; 15 min of washes
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(3 · 5 min) with PBS Tween 3% and 10% goat serum (Jacques
Boys, Reims, France), 20 min of incubation with ﬂuorescein
isothiocyanate-labelled antibody (Beckman Coulter, Marseille,
France) and Texas red-labelled antibody (Jackson Immunore-
search, Suffolk, UK), ‘and a wash step as described above.
Finally, slides were rinsed with de-ionized water for 5 min
and air-dried for 5 min.
Reading and interpretation of slides
After the drying step, the slides were treated within 1 min.
Brieﬂy, each slide was analysed with a ﬂuorescent camera
analyser (InoDiag, La Ciotat, France) after, successively,
365-nm, 470-nm and 594-nm light exposure for 0.2 min each,
and arbitrary unit values were automatically allotted for each
spot using the data-processing software package Inosoft 4.4-1
(InoDiag, La Ciotat, France). The ﬁrst reading at 365 nm
determined the area of each spot and screened for the presence
of all the antigens, and allowed a calculation of the surface of
the antigen deposit (Fig. 1). The second reading at 470 nm
measured the ﬂuorescence level of each spot deposit, using the
view of the antigen determined at 365 nm for the spot area.
The signal was converted into a grey-scale pixel image for
detection and quantiﬁcation of IgG. Normalization was per-
formed by using a coefﬁcient (IgG spot ﬂuorescence val-
ues ⁄ IgM spot ﬂuorescence values). The third reading at
594 nm was automatically processed, as described above, for
470 nm for IgM ‘detection and quantiﬁcation, but was not used
for IE.
Fifty lL of the dilution (1 ⁄ 128) prepared as described above
were used for the test. The analysis was validated when all
spots were detected after the reading at 365 nm and when the
ﬂuorescence level of control spots, read at 470 nm and 594 nm,
was detected.
Internal controls were used to validate each slide. Positive
controls allowed the technical validation of the slides with
the control of the sera distribution and the conjugate distribu-
tion. When rheumatoid factor and ⁄or antinuclear antibodies
were detected, an alert appeared indicating a false-positive
result.
When the ﬂuorescence of the S. aureus spot read at 470 nm
was >20 000, the serum deposit was validated. When the
human IgG spot read at 470 nm was >15 000 and when the
human IgM spot read at 594 nm was >6000, the secondary
antibody deposit and quality were conﬁrmed. Negative con-
trols allowed detection of rheumatoid factor and antinuclear
antibodies, which may cause false-positive results.When the
dsDNA spot read at 470 nm for the IgG ﬂuorescence was
>1300 and the reading at 594 nm for the IgM was >750,
antinuclear antibodies were detected. When the human IgG
spot read at 594 nm was >3500, rheumatoid factor was
detected.
Reproducibility assays
The assays included a total of 44 sera collected from January to
August 2007 in our laboratory. These sera were tested with the
reference technique (IFA). These sera were sent with a
presumptive diagnosis of C. burnetii or Bartonella spp. IE.
Relevant clinical and epidemiological data were obtained for
each sample. IE was diagnosed using the modiﬁed Duke
criteria and the serological cut-off described above. The sera
were tested three times with the InoDiag method. Tested sera
included 18 sera obtained from patients with C. burnetii IE and
16 sera obtained from patients with Bartonella spp. IE (eight
with Bartonella henselae IE and eight with Bartonella quintana
IE). No sera were available from patients with B. melitensis and
L. pneumophila IE.
Ten control sera that tested negative with the reference
method were also tested. These control sera were obtained
from pregnant women systematically tested during preg-
nancy.
A blind test was performed by another team in an
endocarditis centre at Georges Pompidou Hospital, Paris
France. For this assay, all the sera were tested with manual
IFA. The IFA process and diagnostic criteria were identical to
those described above. For C. burnetii, six patients with IE were
tested, and for Bartonella henselae, 14 patients with IE were
tested. No sera were available from patients with L. pneumo-
phila and B. melitensis IE.
Negative sera from 63 patients were tested.
Statistical analysis
The three InoDiag cut-offs were established in ﬂuorescence
values. The ﬁrst cut-off was chosen with the best sensitivity
and negative predictive value, the third cut-off was chosen














Fig. 1. Serum of a patient with acute Q fever.
1114 Clinical Microbiology and Infection, Volume 14 Number 12, December 2008
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 1112–1118
medium cut-off was used as a grey zone. The sensitivity,
speciﬁcity and positivity of C. burnetii, Bartonella henselae,
Bartonella quintana, B. melitensis and L. pneumophila detection
were calculated using receiver operating characteristic curves
(Graph pad prism5.0, Green Pad Software, La Jolla, CA, USA)
of the InoDiag method and were compared to those of the
reference techniques (manual IFA and ELISA), for each cut-off.
IgG testing was performed for each antigen. In order to
determine the relationship between the automated technique
and the reference techniques, a Pearson correlation coefﬁ-
cient was determined for each antigen using SPSS 15
software.
When p <0.01, the Pearson correlation was considered
signiﬁcant. The reproducibility was analysed using the one-
way non-parametric test ANOVA (Graph pad prism5.0), and
when p <0.05, the difference was considered signiﬁcant.
Algorithm of interpretation
The algorithm of interpretation is presented in Fig 2. Brieﬂy,
if the serum is negative for C. burnetii phase II, for Bartonella
quintana, for L. pneumophila and for B. melitensis, it is con-
sidered to be negative for endocarditis independently of
the ﬂuorescence level for other antigens. If the serum is
positive for both C. burnetii phase II and C. burnetii phase I,
endocarditis due to C. burnetii is diagnosed. If the serum is
positive for C. burnetii phase II and negative for C. burnetii
phase I, the software checks ﬂuorescence for Bartonella spp. If
the serum is positive for Bartonella spp., a recent infection due
to C. burnetii or Bartonella spp. is diagnosed. If the serum is
negative for Bartonella spp., the software checks ﬂuorescence
for Legionella. If the serum is positive, a recent infection due to
C. burnetii or L. pneumophila is diagnosed. If the serum is
negative, a recent infection due to C. burnetii is diagnosed. If
the serum is positive for both Bartonella quintana and Bartonella
henselae, endocarditis due to Bartonella spp is diagnosed. If the
serum is positive for Bartonella quintana and negative for
Bartonella henselae, a chronic bacteraemia or endocarditis due to
Bartonella quintana is diagnosed. If the serum is positive only
for L. pneumophila, endocarditis due to Legionella is diagnosed.
If the serum is positive only for B. melitensis, endocarditis due
to Brucella is diagnosed.
RESULTS
Validation of slides
Ten of the 261 (4%) tested slides were rejected
because of lack of ﬂuorochrome (n = 6), due to
bubbles in the incubation chamber, serum omis-
sion (n = 2), and dust artefacts (n = 2). ‘The
rejected slides were not analysed, because no
ﬂuorescence was detected. The slides were re-
tested, and no problem was noted.’
Establishment of cut-offs
‘The three cut-offs were measured in ﬂuorescence
values for each antigen (Fig. 3).
For the ﬁrst, sera were positive for C. burnetii
phase I and phase II when IgG was >2000 and
>4000, respectively; for Bartonella quintana and
Bartonella henselae when IgG was >2500 and
>4000, respectively; for L. pneumophila when IgG
was >1800; and for B. melitensis when IgG was
>6000. Using these three cut-offs, the InoDiag
technique was compared to reference techniques
for each antigen. Sera were classiﬁed into four
groups, i.e. negative, weakly positive, positive
and very positive.
The median was calculated for each group. A
signiﬁcant correlation (p <0.01) was noted for
C. burnetii IgG phase I and phase II detection; the
Pearson correlation was equal to 0.80 and 0.83,
respectively. A signiﬁcant correlation (p <0.01)
was noted for Bartonella henselae and Bartonella
quintana IgG detection; the Pearson correlations

























































Fig. 2. Algorithm of interpretation
for infection blood negative culture
endocarditis.
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B. melitensis IgG detection, one serum was used in
triplicate. A signiﬁcant correlation was noted
(p <0.01); the Pearson correlation was equal to
0.94. For L. pneumophila IgG detection, a signiﬁ-
cant correlation (p <0.01) was noted; the Pearson
correlation was equal to 0.86.
InoDiag performances
Following evaluation of the performance of the
InoDiag method as compared to the reference
techniques, the best performance of the InoDiag
technique, for the diagnosis of C. burnetii, Barto-
nella spp., L. pneumophila and B. melitensis IE, was
obtained using the ﬁrst cut-off. Performances
were calculated for each antigen. For both phase I
and phase II of C. burnetii IgG detection, we had a
sensitivity (Se) of 87.5% and a speciﬁcity (Sp) of
99%. For Bartonella henselae, we had an Se and an
Sp of 90%. For Bartonella quintana, we had an Se of
72% and an Sp of 96%. For B. melitensis, we had
an Se of 100% and an Sp of 99%. For L. pneumo-
phila, we had an Se of 100% and an Sp of 99%.
The best speciﬁcity was obtained using the second
and third cut-offs (Table 1). All cases of endocar-
ditis were identiﬁed, including ten cases of
C. burnetii IE and ten cases of Bartonella spp. IE.
‘The discrepancy between our reference tech-
nique and the InoDiag test was analysed. There
was a serum sample for Bartonella spp. that was
positive according to the InoDiag method, but
negative according to the manual IFA. The serum
was retested, using the two methods, and was
positive according to both the InoDiag test and
the manual IFA. In fact, the titre was equal to
1 ⁄ 400 for the Bartonella spp. A western blot
analysis conﬁrmed the diagnosis of IE [16]. The
MACAM allowed the detection of an IE due to





Coxiella burnetii phase I
Cut-off 1 87.5 99
Cut-off 2 75 99.6
Cut-off 3 50 100
Coxiella burnetii phase II
Cut-off 1 88 99
Cut-off 2 78 100
Cut-off 3 44 100
Brucella melitensis
Cut-off 1 100 99
Cut-off 2 100 99
Cut-off 3 100 100
Legionella pneumophila
Cut-off 1 100 99.6
Cut-off 2 66 100
Cut-off 3 33 100
Bartonella quintana
Cut-off 1 72 96
Cut-off 2 54 99
Cut-off 3 54 99
Bartonella henselae
Cut-off 1 90 100
Cut-off 2 81.8 100
Cut-off 3 54 100
Sensitivity and speciﬁcity of IgG detection are shown for each cut-off of Coxiella
burnetii phase I and II, B. melitensis, L. pneumophila, B. quintana, B. henselae.
























































































































Fig. 3. Comparison of InoDiag cut-offs with the reference method, the manual immunoﬂuorescence assay (IFA).
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Bartonella spp., which was not detected with the
reference technique. The cross-reaction among
sera was analysed. Antinuclear antibodies were
detected in ﬁve sera, and rheumatoid factors were
detected in three sera. One serum from C. burnetii
endocarditis exhibited titres for Bartonella quintana
caused by cross-reaction between Bartonella spp.
and C. burnetii [14], and one serum from C. bur-
netii endocarditis exhibited titres for L. pneumo-
phila [19]. No cross-reaction was observed with
the negative control, except for a serum from a
patient with myeloma, which was positive only
for Bartonella quintana. Using the rule of algorithm
interpretation, all IEs were automatically reclas-
siﬁed into the determined category. Using the
algorithm, the global negative and positive pre-
dictive value of the test was 100% for the
diagnosis of IE due to the four pathogens tested.
Reproducibility analysis
The reproducibility of the InoDiag method was
evaluated using triplicate testing for each serum.
For C. burnetii, Bartonella henselae and Bartonella
quintana, there was no signiﬁcance difference
among the triplicates. The p-values for C. burnetii
phase I and phase I were 0.91 and 0.45, respec-
tively. For Bartonella henselae and Bartonella quin-
tana, the p-values were 0.7 and 0.8, respectively.
The performance of the InoDiag method was
compared with that of the reference technique
(manual IFA) through this testing and using
receiver operating characteristic curves (Graph
pad prism5.0). There was an Se of 92% and an Sp
of 88% for C. burnetii phase I, and an Se of 90%
and an Sp of 82% for C. burnetii phase II. For
Bartonella henselae and Bartonella quintana, there
was an Se of 72% and an Sp of 96%, and an Se of
92% and an Sp of 70%, respectively. In George
Pompidou Hospital, Paris, a blind test was done;
the performances obtained for C. burnetii phase I
and phase II were Se = 100% and Sp = 94%, and
Se = 84% and Sp = 81%, respectively. For Barto-
nella henselae, performances were Se = 93% and
Sp = 75%, and for Bartonella quintana they were
Se = 92% and Sp = 67%’.
DISCUSSION
The MACAM from InoDiag is a useful method
that can provide a rapid serodiagnosis of blood
culture-negative endocarditis.
InoDiag includes a platformwith automatic IFA
testing and MACAM as the format of tests. This
technique is rapid, requiring only 1 h, as compared
to the 3 h required for IFA. ‘The process is totally
automated, from the serum incubation to the
automatic reading and ‘interpretation, except for
the serum deposit, thus avoiding mistakes of
interpretation. Lack of reproducibility is a major
limitation of manual immunoﬂuorescence serol-
ogy. Serology results are not comparable from one
laboratory to another, and may even vary with the
observer andwithin the same laboratory [2,20]. The
MACAM incorporated four internal spots to con-
trol six steps of the serology. Control spots were
automatically analysed by the software, and their
interpretation was not dependent upon the inves-
tigator. With these four internal control spots, the
negative control and the positive controls are not
necessary. This is a critical advantage of the
multiplexed serology test. Indeed, in this study,
with the manual test, four positive controls were
necessary (one for each antigen). Furthermore,
usingS. aureus as a systematic control, it was found
that two sera were omitted. This problem occurred
during the serum deposit phase, the only manual
step of the InoDiag test. This omissionwouldnot be
detected by manual IFA and ELISA, yielding a
false-negative result. In contrast, one serum that
was positive according to the MACAM yielded a
false-negative result with the manual IFA. This
makes it apparent that human mistakes cannot be
detected using the classical manual IFA. Rheuma-
toid factors were automatically detected, and are a
criterion for the diagnosis of endocarditis accord-
ing to the modiﬁed Duke criteria [18]. The MA-
CAM allowed the miniaturization of IFA. The
amount of antigen solution used is 1 nL per slide,
vs. 1 lL per slide for IFA, which makes this
multiplexed serology much less expensive with
respect to the cost of antigens. Six quantitative
serological tests were run simultaneously using
5 lL of the serum, 100-fold less than the amount
required to perform similar tests using manual
serology. Quantiﬁcation of speciﬁc antibodies
requires a single serumdilution (1 ⁄ 128) as opposed
to the multiple dilutions required for manual
serology, and thus reduces both the duration of
manipulation and the risk of error. Moreover, if
necessary, other IFAs could be performed for IgM
and IgA to improve the diagnosis. If the serum
analysis leads to a false diagnosis, control of
nuclear antibodies and or rheumatoid factors can
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be performed; however, this would signiﬁcantly
increase the volume of serum consumed.
Serological testing with the InoDiag automated
IFA is a rapid, miniaturized procedure that allows
simultaneous testing of sera for several antigens
using a multiplexed format. The MACAM format
has an automated platform similar to those used
for the ELISA assay. The digitization of ﬂuores-
cent spots allowed, for the ﬁrst time, the possi-
bility of exchange of the serological results among
benchworkers and laboratories.
Moreover, it allows the screening of all anti-
gen-containing spots directly on the image and
also the detection of artefacts, e.g. dust, which
could hamper the diagnosis. The numerical data
would ensure a permanent and suitable record
for further analysis and interpretation of the
serological data. Moreover, the digitization of
the IFA allowed further internet exportation of
the data. The MACAM format achieved a level
of reproducibility that has never been achieved
before in immunoﬂuorescence serology.
To summarize, an antigen-based microarray
was developed as a proof of concept, incorporat-
ing for the ﬁrst time entire bacteria such as those
incorporated as antigens in conventional IFA. A
serum specimen can be tested simultaneously for
most of the pathogens responsible for one syn-
drome. The MACAM and automated immuno-
ﬂuorescence represent a new generation of
serological tests [21].
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